Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
Gut Microbiota Composition Is Associated With the Efficacy of Delta-24-Rgdox in Malignant Gliomas, Natalie M Meléndez-Vázquez, Teresa T Nguyen, Xuejun Fan, et al.
Gut Microbiota Composition Is Associated With the Efficacy of Delta-24-RGDOX in Malignant Gliomas, Natalie M Meléndez-Vázquez, Teresa T Nguyen, Xuejun Fan, et al.
Pressing Issues for Oral Care Quality Improvement: Findings From the EU Deliver Project, Paulo Melo, Leonor Frey-Furtado, Daniela Correia, et al.
Mimosa: A Resource Consisting of Improved Methylome Prediction Models Increases Power to Identify DNA Methylation-Phenotype Associations, Hunter J Melton, Zichen Zhang, Hong-Wen Deng, et al.
Summit-Fa: A New Resource for Improved Transcriptome Imputation Using Functional Annotations, Hunter J Melton, Zichen Zhang, and Chong Wu
Postmortem-Derived iPSC Models in Substance Use Disorders Research, Emily Frances Mendez and Consuelo Walss-Bass
An Image-Driven Micromechanical Approach to Characterize Multiscale Remodeling in Infarcted Myocardium, Emilio A Mendiola, Sunder Neelakantan, Qian Xiang, et al.
Sensitivity Analysis With Iterative Outlier Detection for Systematic Reviews and Meta-Analyses, Zhuo Meng, Jingshen Wang, Lifeng Lin, et al.
POLARIS: A Phase 2 Trial of Encorafenib Plus Binimetinib Evaluating High-Dose and Standard-Dose Regimens in Patients With BRAF V600-Mutant Melanoma With Brain Metastasis, Alexander M Menzies, Georgina V Long, Amiee Kohn, et al.
Gestational Diabetes Augments Group B Streptococcus Infection by Disrupting Maternal Immunity and the Vaginal Microbiota, Vicki Mercado-Evans, Marlyd E Mejia, Jacob J Zulk, et al.
Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients, Funda Meric-Bernstam, Antoine Hollebecque, Junji Furuse, et al.
Assessment of Patient-Derived Xenograft Growth and Antitumor Activity: The NCI PDXNet Consensus Recommendations, Funda Meric-Bernstam, Michael W Lloyd, Soner Koc, et al.
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial, Funda Meric-Bernstam, Vicky Makker, Ana Oaknin, et al.
Prediction Accuracy of Soil Chemical Parameters by Field- and Laboratory-Obtained vis-NIR Spectra after External Parameter Orthogonalization, Konrad Metzger, Frank Liebisch, Juan M Herrera, et al.
PIGA Mutations and Glycosylphosphatidylinositol Anchor Dysregulation in Polyposis-Associated Duodenal Tumorigenesis, Elena Meuser, Kyle Chang, Angharad Walters, et al.
SMYD5 Is a Ribosomal Methyltransferase That Catalyzes RPL40 Lysine Methylation To Enhance Translation Output and Promote Hepatocellular Carcinoma, Bisi Miao, Ling Ge, Chenxi He, et al.
The Multifaceted Role of Neutrophils in NSCLC in the Era of Immune Checkpoint Inhibitors, Shucheng Miao, Bertha Leticia Rodriguez, and Don L Gibbons
Use of Web-Based Decision Support To Improve Informed Choice for Chemoprevention: A Qualitative Analysis of Pre-Implementation Interviews (SWOG S1904), Alissa M Michel, Haeseung Yi, Jacquelyn Amenta, et al.
Immune Infiltration at the Primary Tumor Is Associated With Clinical Outcome of Patients With Extranodal Extension of Lymph Node Metastasis in Oral Cancer, Chieko Michikawa, Frederico O Gleber-Netto, Curtis R Pickering, et al.
Enolase Inhibitors As Therapeutic Leads for Naegleria fowleri Infection, Jillian E Milanes, Victoria C Yan, Cong-Dat Pham, et al.
Patients With Advanced Cancer and Their Spouses Parenting Minor Children: The Role of the Relationship Context in Parenting Concerns, Kathrin Milbury, Sujin Ann-Yi, Morgan Jones, et al.
Dyadic Yoga for Head and Neck Cancer Patients Undergoing Chemoradiation and their Family Caregivers, Kathrin Milbury, David I Rosenthal, Yisheng Li, et al.
MTOR Maintains Endothelial Cell Integrity To Limit Lung Vascular Injury, Michelle Warren Millar, Rauf A Najar, Spencer A Slavin, et al.
Efficacy of Novel Agents Against Cellular Models of Familial Platelet Disorder With Myeloid Malignancy (FPD-MM), Christopher P Mill, Warren C Fiskus, Courtney D DiNardo, et al.
Prolonged Cytopenias After Immune Effector Cell Therapy and Lymphodepletion in Patients With Leukemia, Lymphoma and Solid Tumors, Anne Miller, Rachel Daum, Tao Wang, et al.